Our Patient’s Autologous Stem Cells are Drugs: The FDA Moving Down a Dangerous Slippery Slope
By Christopher J. Centeno, MD Adult autologous stem cells (A-ASC’s) show great promise in research and early pre-clinical/clinical use. These cells have the potential to revolutionize medicine by repairing tissues directly or assisting in tissue healing.1 What you may not realize is that a herculean power struggle going on behind the scenes where the Food and Drug more »